UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 12, 2021
Accession Number:
Submission Type:
CIK:
0001729214
Company Name:
XORTX Therapeutics Inc.
File Number:
333-258741